Angelo Gordon & Co’s Trillium Therapeutics Inc. TRIL Stock Holding History

Angelo Gordon & Co’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-125,000	Closed	-$2.19M	–	300
2021 Q3	$2.19M	Buy	+125,000	New	+$1.46M	0.12%	73

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Angelo Gordon & Co's TRIL Position: Q4 2021 in Review

Angelo Gordon & Co sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 125,000 shares — an estimated $2.19M sold.

Angelo Gordon & Co first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $2.19M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Angelo Gordon & Co reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Angelo Gordon & Co sold 125,000 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $2.19M.
Angelo Gordon & Co first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Angelo Gordon & Co's Trillium Therapeutics Inc. position peaked at $2.19M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Angelo Gordon & Co's 13F filing for Q4 2021, filed 14 Feb 2022.